- Home
- IPHA vs NXDT Comparison
IPHA vs NXDT Comparison
Compare IPHA & NXDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IPHA | NXDT |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.2M | 170.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | IPHA | NXDT |
|---|---|---|
| Price | $1.85 | $3.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 22.5K | ★ 133.6K |
| Earning Date | 09-17-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.99 |
| Revenue | ★ $14,839,695.00 | N/A |
| Revenue This Year | $22.29 | N/A |
| Revenue Next Year | $43.90 | N/A |
| P/E Ratio | ★ N/A | $6.41 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.47 | $5.89 |
| 52 Week High | $3.51 | $13.07 |
Technical Indicators
Market Signals| Indicator | IPHA | NXDT |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 60.10 |
| Support Level | $1.85 | $2.65 |
| Resistance Level | $1.92 | $2.92 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 25.58 | 65.07 |
Price Performance
Historical ComparisonAbout IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.